Skip to main content

Table 3 Univariate analysis of the degree of symptom relief

From: Symptom palliation of hypofractionated radiotherapy for patients with incurable inflammatory breast cancer

Variables

HR

95% CI

p value

Pathology (IDC vs. IMC)

0.36

0.06–2.23

0.27

Previous CTx or HTx history (Yes vs. No)

0.68

0.14–3.25

0.63

Prescription dose (< 80 Gy4 vs. ≥80 Gy4)

0.70

0.05–5.12

0.06

Symptom type (single vs. combination)

3.57

1.87–49.08

0.02

Tumor response (PR vs. SD + PD)

0.16

0.01–1.84

0.14

  1. HR hazard ratio, CI confidential interval, IDC invasive ductal carcinoma, IMC invasive medullary carcinoma, CTx chemotherapy, HTx hormone therapy, Gy4 biologically effective dose of alpha/beta ratio 4, PR partial response, SD stable disease, PD progressive disease
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us